Autres langues Avivagen Inc.

Actions

VIV

CA05382F2026

Temps Différé Toronto S.E. Autres places de cotation 15:30:00 05/03/2024			Varia. 5j.	Varia. 1 janv.
0,005 ^CAD	-.--%		-.--%	-.--%

2023	Avivagen Inc. annonce une nouvelle commande de 500 kg pour OxC-beta	CI
2023	Avivagen Inc. déclare ses résultats pour le troisième trimestre et les neuf mois terminés le 31 juillet 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA	24/04
Canadian Investment Regulatory Organization Trading Halt - VIV	06/03
Avivagen Inc. Announces New 500 Kg Order for OxC-beta	17/10/23
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	29/09/23
Avivagen Brief: Announcing several corporate updates, relating to allowances of patents, a waiver of an interest payment on its senior secured debentures and continuation of the strategic review process	31/07/23
Avivagen Secures New Orders for 1.1 Tons of Oxc-Beta Livestock Product	24/07/23
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta? Livestock Product	24/07/23
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	06/06/23
Avivagen Announces Significant Increase in Sales to an Existing Customer	26/05/23
Avivagen Reports Increase in Sales to Existing Customer	25/05/23
Avivagen Inc. Announces Significant Increase in Sales to an Existing Customer	25/05/23
Avivagen Brief: Announcing "Significant" Increase in Sales to an Existing Customer	25/05/23
Avivagen Launches Strategic Review; Comes After Soaring 50% Yesterday	18/05/23
Avivagen Brief: Announcing Review of Strategic Alternatives	18/05/23
Avivagen Announces Review of Strategic Alternatives	18/05/23
Avivagen Inc. Announces Board Changes	19/04/23
Avivagen Narrows Fiscal Q1 Loss, Revenue Falls; Says Will Need Cash Proceeds to Continue as Going Concern	17/03/23
Avivagen Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	17/03/23
Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth	22/02/23
Avivagen Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	21/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Avivagen Inc.

Actions

VIV

CA05382F2026

Autres langues

Filtres